West Sussex Health and Social Care NHS Trust
Total Page:16
File Type:pdf, Size:1020Kb
SUSSEX PARTNERSHIP NHS FOUNDATION TRUST MEDICINES FORMULARY GUIDELINE VERSION 26 RATIFYING GROUP (individual formulary Drugs and Therapeutics Group (DTG) decisions and linked guidelines) DATE PUBLISHED July 2021 NEXT REVIEW DATE July 2023 FORMULARY SPONSOR Chief Medical Officer FORMULARY EDITOR Chief Pharmacist LINKED POLICIES AND GUIDELINES Linked policies and antipsychotic Physical health linked guidelines guidelines • Antipsychotics, guidelines for cardiac • Antipsychotics, prescribing guidelines rhythm screening (ECGs) • Asenapine, prescribing guidelines • Antipsychotics, guidelines for the • Clozapine inpatient and community management of weight gain and team policies metabolic disturbances • Clozapine, protocol for the use of • Metformin, information for GPs on its intramuscular injection use with antipsychotics • Clopixol Acuphase, prescribing • Hyperprolactinaemia, prescribing guideline guidelines on the treatment of • Lurasidone, prescribing guidelines antipsychotic induced symptoms • Perinatal mental health, prescribing • Anticoagulants, prescribing guidelines guidelines • Insulin, prescribing guidelines • Rapid tranquilisation policy • Medicines code Long acting antipsychotic guidelines Anxiolytics and hypnotic guidelines • Long acting antipsychotic injections, • Alcohol and benzodiazepine guidelines for use dependence (adults), prescribing • Aripiprazole long acting injection, guidelines for inpatients • Benzodiazepine as anxiolytics (adults), prescribing guidelines prescribing guidelines • Olanzapine long-acting injection, • Benzodiazepines, calculating prescribing guidelines equivalent doses • Paliperidone monthly long acting • Hypnotics (including benzodiazepines) injection, prescribing guidelines and insomnia, prescribing guidelines • Paliperidone palmitate 3-monthly long acting Injection, prescribing guidelines Antidepressant prescribing guidelines Emotionally unstable personality disorder • Antidepressants, prescribing (EUPD), prescribing guidelines guidelines (note there are separate guidelines for adults and CAMHS) • Agomelatine, prescribing guidelines in major depressive episode Bipolar affective disorder linked Substance dependence guidelines guidelines • Alcohol and benzodiazepine • Mood stabilizers, prescribing dependence (adults), prescribing guidelines in bipolar affective disorder guidelines for inpatients • Lithium, prescribing guidelines for • Opiate dependence, prescribing guidelines for inpatients inpatients • Substances and drugs of abuse, a guide to how long they can be detected in the body after consumption • Tobacco dependence pathway Dementia and SOAMHs linked guidelines Attention Deficit Hyperactivity Disorder • Dementia, prescribing guidelines (ADHD) • Behavioural problems in older people, • ADHD Shared care guidelines prescribing guidelines (CAMHS) • Dementia, non-pharmacological • ADHD (adults), prescribing guidelines approaches to challenging behaviour • Guanfacine (CAMHS), prescribing guidelines • Melatonin Shared care guidelines (CAMHS) All prescribing guidelines and policies can be found on the Trust website from the following link: https://www.sussexpartnership.nhs.uk/medication Page 2 of 29 Index 1. Sussex Partnership NHS Foundation Trust: Formulary principles 4 2. SPFT formulary medicines for mental health diagnoses 6 2.1 Hypnotics 6 2.2 Anxiolytics 7 2.3 Antipsychotics 9 2.4 Mood stabilisers 17 2.5 Antidepressants 20 2.6 Medicines used in alcohol and substance dependence 23 2.7 Medicines used in dementia 24 2.8 Medicines used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) 26 2.9 Approved unlicensed medicines use for behaviour that challenges in Autism Spectrum Disorder (ASD) and Learning Difficulties (LD) 28 Page 3 of 29 1. Sussex Partnership NHS Foundation Trust: Formulary principles Only the following medicines can be prescribed to patients within Sussex Partnership NHS Foundation Trust (SPFT): • Medicines associated with their mental health need and diagnoses which are detailed in this formulary and have been approved for use by the Trust’s Drugs and Therapeutics Group (DTG). Senior medical staff in this formulary are defined as consultants, associate specialists and speciality doctors with at least 3 years’ experience. Please note that all medicines in every Trust must be approved for use by the local Area Prescribing Committee (APC) which is led by the Clinical Commissioning Group (CCG) according to each geographical location (East Sussex/ Brighton and Hove/ West Sussex). The newly formed Sussex Health and Care Partnership (SHCP) which spans across all 3 counties is working to align the separate formularies into a single SHCP formulary. Currently the links to each of these formularies can be accessed from the Trust website via this link: https://www.sussexpartnership.nhs.uk/formularies In the joint formularies, each medicine is colour coded. • Only medicines colour coded as green are permitted to be prescribed by the patient’s General Practitioner (GP). If your intention is that the patient’s GP will continue the prescription, please ensure it is coded green before initiating, • Blue coded medicines can only be transferred for GP prescribing once treatment is stabilised (usually after 3 months), • Amber coded medicines are approved for shared care with details outlined in individual shared care guidelines (SCGs), • Red medicines are specialist only medicines which can only be prescribed by a specialist. These include mental health medicines. The prescribing of red coded medicines for mental health can only be prescribed by SPFT clinicians, they cannot be transferred for GP prescribing. • Physical health medicines as approved for use according to the joint formulary by geographical location. You must only prescribe physical health medicines that are coded as green on the joint formularies. Please note that physical health medicines can only be prescribed for inpatients. Physical health medicines must not be prescribed on FP10 in community teams or clinics, except in exceptional and urgent circumstances. The responsibility for prescribing and monitoring physical medicines for patients in community teams or clinics is with the patient’s general practitioner (GP). • Over-the-counter (OTC) medicines if approved for use in the Trust formulary or in the relevant CCG’s joint formulary. • Complementary, essential oils, herbal and homeopathic medicines, if approved for use in the Trust formulary or in the relevant CCG’s joint formulary. N.B. Medicine supply for complementary, essential oils, herbal and homeopathic medicines is only permitted for those included within the formulary. However, if the patient has their own supply of a non-formulary medicine within these product groups then they may be prescribed for use only after a pharmacist has assessed their safety and clinical appropriateness (including assessment of drug interactions). Page 4 of 29 For inpatients; the pharmacist must endorse within the additional information on the front of the drug chart that they have clinically screened each item for use before administration may take place. For non-formulary items; the patient’s own supply must be used for administration. In order to request a new medicine or a new indication (diagnosis) for an existing medicine to be used within the Trust, the process within the ‘formulary, named-patient and unlicensed medicine use request protocol’ must be followed. This protocol is available through this link: https://www.sussexpartnership.nhs.uk/medication-related-guidance All associated forms to this protocol can be accessed through this link: https://www.sussexpartnership.nhs.uk/charts-and-forms • Unlicensed medicines o Wherever clinically appropriate, medicines must be prescribed within their product licence (PL) and within their marketing authorisation (MA). A medicine maybe used outside of its PL (unlicensed medicine) or MA (“off-label” medicine) where there is significant clinical evidence base to support its use and that use has been approved for use by the Drugs and Therapeutic Group (DTG). In the majority of cases, this is for an unlicensed indication but in rare situations may also include route and/ or dosage. o Every request for an unlicensed use of a medicine must be ratified by the Trust’s DTG. A prescriber is not authorised to prescribe an unlicensed medicine in this Trust, unless that use has been ratified by the DTG. A database of all unlicensed uses of medicines including named-patient forms where appropriate will be maintained by the Trust’s pharmacy team. Please ask your pharmacy team for a current copy of the approved unlicensed medicines database. Page 5 of 29 2. SPFT formulary medicines for mental health diagnoses 2.1 Hypnotics Please refer to the following SPFT clinical guidelines and NICE Technical Appraisals (where applicable) for prescribing, administration and monitoring advice: SPFT clinical guidelines NICE Technical Appraisals (found here: https://www.sussexpartnership.nhs.uk/medication- (TA) related-guidance) Hypnotics (including benzodiazepines) and insomnia, TA77: prescribing guidelines http://guidance.nice.org.uk/TA77 Z Drugs (oral) Additional notes, including where unlicensed Zolpidem TA77 First line in older people Zopiclone TA77 Benzodiazepines (oral) Loprazolam TA77 Temazepam TA77 Controlled drug – schedule 3 Oxazepam Only to be used when all other options have failed - unlicensed use (see below) Other oral hypnotics Chloral hydrate Can only be initiated by senior medical staff Clomethiazole Melatonin See unlicensed uses below